Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability
| Image |  |
|---|---|
| Description | scientific article published on 13 June 2019 |
| Author/s | |
| Publication date | June 13, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |